Even though the first studies suggesting that MGMT promoter hypermethylation was an important molecular marker in high-grade gliomas were published almost a decade ago [8-10], the extent of its positive prognostic and predictive value in the different grades of gliomas remains to be determined [11]. This evidence concerns the gene MGMT and glioma.